In addition, NPM1 expression has also been shown to be correlated with prognosis in colorectal cancer, and targeting NPM1 could inhibit the progression of colorectal cancer by activating p53 and inhibiting AKT [10, 19]. This evidence concerns the gene AKT1 and colorectal cancer.